Drugs that modulate aging: The promising yet difficult path ahead

Translational Research

Volumn 163, Issue 5, 2014, Pages 456-465

  Kennedy, Brian K ^a   Pennypacker, Juniper K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Abbreviations; ADRB2; IGF; IIS; insulin like growth factor; insulin IGF signaling; lamin A C; LMNA; National Institute on Aging; NIA; PKA; protein kinase A; silent information regulator 2; SIR2; sirtuin activating compounds; STACs; target of rapamycin; target of rapamycin complex 1; target of rapamycin complex 2; TOR; TORC1; TORC2; Adrenergic receptor

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; RAPAMYCIN; RESVERATROL; SIRTUIN; SMALL MOLECULE TRANSPORT AGENT;

AGING; CHRONIC DISEASE; CLINICAL RESEARCH; DRUG RESEARCH; GENETIC ANALYSIS; HUMAN; LIFE EXTENSION; LONGEVITY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

AGING; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84899562732     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.11.007     Document Type: Review

References (120)

1. C.E. Finch Longevity, senescence and the genome 1990 University Chicago Press Chicago, IL
2. C.E. Finch Evolution in health and medicine Sackler colloquium: evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition Proc Natl Acad Sci U S A 107 Suppl 1 2010 1718 1724
3. G.C. Williams Pleiotropy, natural selection and the evolution of senescence Evolution 11 1957 398 411
4. T.B. Kirkwood Evolution of ageing Nature 270 1977 301 304
5. T.B. Kirkwood Understanding the odd science of aging Cell 120 2005 437 447
6. T.B. Kirkwood, and S.N. Austad Why do we age? Nature 408 2000 233 238
7. P. Ljubuncic, and A.Z. Reznick The evolutionary theories of aging revisited-A mini-review Gerontology 55 2009 205 216
8. S.N. Austad Diverse aging rates in metazoans: targets for functional genomics Mech Ageing Dev 126 2005 43 49
9. B.K. Kennedy The genetics of ageing: insight from genome-wide approaches in invertebrate model organisms J Intern Med 263 2008 142 152
10. M.R. Klass A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results Mech Ageing Dev 22 1983 279 286
11. C. Kenyon, J. Chang, E. Gensch, A. Rudner, and R. Tabtiang A C. elegans mutant that lives twice as long as wild type Nature 366 1993 461 464
12. D.B. Friedman, and T.E. Johnson Three mutants that extend both mean and maximum life span of the nematode, Caenorhabditis elegans, define the age-1 gene J Gerontol 43 1988 B102 B109
13. M.R. Rose, and B. Charlesworth Genetics of life history in Drosophila melanogaster. II. Exploratory selection experiments Genetics 97 1981 187 196
14. A.M. Clark, and A.B. Gould Genetic control of adult life span in Drosophila melanogaster Exp Gerontol 5 1970 157 162
15. V.D. Longo, G.S. Shadel, M. Kaeberlein, and B. Kennedy Replicative and chronological aging in Saccharomyces cerevisiae Cell Metab 16 2012 18 31
16. M. Kaeberlein Lessons on longevity from budding yeast Nature 464 2010 513 519
17. R.K. Mortimer, and J.R. Johnston Life span of individual yeast cells Nature 183 1959 1751 1752
18. J. Sun, S.P. Kale, A.M. Childress, C. Pinswasdi, and S.M. Jazwinski Divergent roles for RAS1 and RAS2 in yeast longevity J Biol Chem 269 1994 18638 18645
19. V.D. Longo, E.B. Gralla, and J.S. Valentine Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo J Biol Chem 271 1996 12275 12280
20. B.K. Kennedy, N.R. Austriaco, J. Zhang, and L. Guarente Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae Cell 80 1995 485 496
21. L.S. Luckinbill, and M.J. Clare Selection for life span in Drosophila melanogaster Heredity (Edinb) 55 Pt 1 1985 9 18
22. M. Kaeberlein, R.W. Powers III, and K.K. Steffen et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients Science 310 2005 1193 1196
23. R.W. Powers III, M. Kaeberlein, S.D. Caldwell, B.K. Kennedy, and S. Fields Extension of chronological life span in yeast by decreased TOR pathway signaling Genes Dev 20 2006 174 184
24. B. Hamilton, Y. Dong, and M. Shindo et al. A systematic RNAi screen for longevity genes in C. elegans Genes Dev 19 2005 1544 1555
25. S.S. Lee, R.Y. Lee, A.G. Fraser, R.S. Kamath, J. Ahringer, and G. Ruvkun A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity Nat Genet 33 2003 40 48
26. M. Hansen, A.L. Hsu, A. Dillin, and C. Kenyon New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen PLoS Genet 1 2005 119 128
27. A. Dillin, A.L. Hsu, and N. Arantes-Oliveira et al. Rates of behavior and aging specified by mitochondrial function during development Science 298 2002 2398 2401
28. D. Chen, K.Z. Pan, J.E. Palter, and P. Kapahi Longevity determined by developmental arrest genes in Caenorhabditis elegans Aging Cell 6 2007 525 533
29. S.P. Curran, and G. Ruvkun Lifespan regulation by evolutionarily conserved genes essential for viability PLoS Genet 3 2007 e56
30. Y. Kim, and H. Sun Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan Aging Cell 6 2007 489 503
31. L. Fontana, L. Partridge, and V.D. Longo Extending healthy life span-from yeast to humans Science 328 2010 321 326
32. C.J. Kenyon The genetics of ageing Nature 464 2010 504 512
33. E.D. Smith, M. Tsuchiya, and L.A. Fox et al. Quantitative evidence for conserved longevity pathways between divergent eukaryotic species Genome Res 18 2008 564 570
34. J.Z. Morris, H.A. Tissenbaum, and G. Ruvkun A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans Nature 382 1996 536 539
35. D.J. Clancy, D. Gems, and L.G. Harshman et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein Science 292 2001 104 106
36. M. Tatar, A. Kopelman, D. Epstein, M.P. Tu, C.M. Yin, and R.S. Garofalo A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function Science 292 2001 107 110
37. T. Vellai, K. Takacs-Vellai, Y. Zhang, A.L. Kovacs, L. Orosz, and F. Muller Genetics: influence of TOR kinase on lifespan in C. elegans Nature 426 2003 620
38. P. Kapahi, B.M. Zid, T. Harper, D. Koslover, V. Sapin, and S. Benzer Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway Curr Biol 14 2004 885 890
39. K. Jia, D. Chen, and D.L. Riddle The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span Development 131 2004 3897 3906
40. B. Meissner, M. Boll, H. Daniel, and R. Baumeister Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans J Biol Chem 279 2004 36739 36745
41. S.J. Lin, P.A. Defossez, and L. Guarente Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae Science 289 2000 2126 2128
42. C.M. Gendron, N. Minois, V.D. Longo, S.D. Pletcher, and J.W. Vaupel Biodemographic trajectories of age-specific reproliferation from stationary phase in the yeast Saccharomyces cerevisiae seem multiphasic Mech Ageing Dev 124 2003 1059 1063
43. M. Kaeberlein, M. McVey, and L. Guarente The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev 13 1999 2570 2580
44. L.C. Enns, J.F. Morton, and P.R. Treuting et al. Disruption of protein kinase A in mice enhances healthy aging PLoS One 4 2009 e5963
45. B. Rogina, and S.L. Helfand Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc Natl Acad Sci, USA 101 2004 15998 16003
46. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230
47. D.E. Harrison, R. Strong, and Z.D. Sharp et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice Nature 460 2009 392 395
48. C. Chen, Y. Liu, and P. Zheng mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells Sci Signal 2 2009 ra75
49. L. Yan, D.E. Vatner, and J.P. O'Connor et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress Cell 130 2007 247 258
50. H.M. Brown-Borg, K.E. Borg, C.J. Meliska, and A. Bartke Dwarf mice and the ageing process Nature 384 1996 33
51. M. Bluher, B.B. Kahn, and R.C. Kahn Extended longevity in mice lacking the insulin receptor in adipose tissue Science 299 2003 572 574
52. Y. Li, W.J. Wang, and H. Cao et al. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations Hum Mol Genet 18 2009 4897 4904
53. M. Soerensen, S. Dato, and K. Christensen et al. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data Aging Cell 9 2010 1010 1017
54. L. Pawlikowska, D. Hu, and S. Huntsman et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity Aging Cell 8 2009 460 472
55. C.V. Anselmi, A. Malovini, and R. Roncarati et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study Rejuvenation Res 12 2009 95 104
56. F. Flachsbart, A. Caliebe, and R. Kleindorp et al. Association of FOXO3A variation with human longevity confirmed in German centenarians Proc Natl Acad Sci U S A 106 2009 2700 2705
57. B.J. Willcox, T.A. Donlon, and Q. He et al. FOXO3A genotype is strongly associated with human longevity Proc Natl Acad Sci U S A 105 2008 13987 13992
58. Y. Suh, G. Atzmon, and M.O. Cho et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians Proc Natl Acad Sci U S A 105 2008 3438 3442
59. L. Zhao, F. Yang, and K. Xu et al. Common genetic variants of the beta2-Adrenergic receptor affect its translational efficiency and are associated with human longevity Aging Cell 11 2012 1094 1101
60. C. Vezina, A. Kudelski, and S.N. Sehgal Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle J Antibiot (Tokyo) 28 1975 721 726
61. M.N. Stanfel, L.S. Shamieh, M. Kaeberlein, and B.K. Kennedy The TOR pathway comes of age Biochim Biophys Acta 1790 2009 1067 1074
62. D.W. Lamming, L. Ye, D.M. Sabatini, and J.A. Baur Rapalogs and mTOR inhibitors as anti-Aging therapeutics J Clin Invest 123 2013 980 989
63. S.C. Johnson, P.S. Rabinovitch, and M. Kaeberlein mTOR is a key modulator of ageing and age-related disease Nature 493 2013 338 345
64. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
65. C. Selman, J.M. Tullet, and D. Wieser et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science 326 2009 140 144
66. J.M. Flynn, M.N. O'Leary, and C.A. Zambataro et al. Late life rapamycin treatment reverses age-related heart dysfunction Aging Cell 12 2013 851 862
67. S. Sarkar, B. Ravikumar, R.A. Floto, and D.C. Rubinsztein Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine- expanded huntingtin and related proteinopathies Cell Death Differ 16 2009 46 56
68. P. Spilman, N. Podlutskaya, and M.J. Hart et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease PLoS One 5 2010 e9979
69. C. Malagelada, Z.H. Jin, V. Jackson-Lewis, S. Przedborski, and L.A. Greene Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease J Neurosci 30 2010 1166 1175
70. J.E. Wilkinson, L. Burmeister, and S.V. Brooks et al. Rapamycin slows aging in mice Aging Cell 11 2012 675 682
71. Y. Zhang, A. Bokov, and J. Gelfond et al. Rapamycin Extends Life and Health in C57BL/6 mice J Gerontol A Biol Sci Med Sci 69 2014 119 130
72. D.D. Sarbassov, S.M. Ali, and S. Sengupta et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol Cell 22 2006 159 168
73. R. Loewith, and M.N. Hall Target of rapamycin (TOR) in nutrient signaling and growth control Genetics 189 2011 1177 1201
74. J. Gallinetti, E. Harputlugil, and J.R. Mitchell Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR Biochem J 449 2013 1 10
75. M.V. Blagosklonny Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans) Cell Cycle 9 2010 683 688
76. D.R. Bolster, S.J. Crozier, S.R. Kimball, and L.S. Jefferson AMP-Activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling J Biol Chem 277 2002 23977 23980
77. M.C. Mendoza, E.E. Er, and J. Blenis The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation Trends Biochem Sci 36 2011 320 328
78. M. Touzot, J.P. Soulillou, and J. Dantal Mechanistic target of rapamycin inhibitors in solid organ transplantation: from benchside to clinical use Curr Opin Organ Transplant 17 2012 626 633
79. D.W. Lamming, L. Ye, and P. Katajisto et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity Science 335 2012 1638 1643
80. J.A. Hall, J.E. Dominy, Y. Lee, and P. Puigserver The sirtuin family's role in aging and age-Associated pathologies J Clin Invest 123 2013 973 979
81. C. Burnett, S. Valentini, and F. Cabreiro et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila Nature 477 2011 482 485
82. G. Rizki, T.N. Iwata, and J. Li et al. The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO PLoS Genet 7 2011 e1002235
83. B. Rogina, S.L. Helfand, and S. Frankel Longevity regulation by Drosophila Rpd3 deacetylase and caloric restriction Science 298 2002 1745
84. K.K. Banerjee, C. Ayyub, S.Z. Ali, V. Mandot, N.G. Prasad, and U. Kolthur-Seetharam dSir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner Cell Rep 2 2012 1485 1491
85. D. Herranz, M. Munoz-Martin, and M. Canamero et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-Associated cancer Nat Commun 1 2010 3
86. A. Satoh, C.S. Brace, and N. Rensing et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH Cell Metab 18 2013 416 430
87. Y. Kanfi, S. Naiman, and G. Amir et al. The sirtuin SIRT6 regulates lifespan in male mice Nature 483 2012 218 221
88. D.A. Sinclair, and L. Guarente Extrachromosomal rDNA circles-A cause of aging in yeast Cell 91 1997 1033 1042
89. W. Dang, K.K. Steffen, and R. Perry et al. Histone H4 lysine 16 acetylation regulates cellular lifespan Nature 459 2009 802 807
90. E.X. Kwan, E.J. Foss, and S. Tsuchiyama et al. A natural polymorphism in rDNA replication origins links origin activation with calorie restriction and lifespan PLoS Genet 9 2013 e1003329
91. M. Kaeberlein The ongoing saga of sirtuins and aging Cell Metab 8 2008 4 5
92. J.A. Baur, D. Chen, and E.N. Chini et al. Dietary restriction: standing up for sirtuins Science 329 2010 1012 1013 author reply 3-4
93. K.T. Howitz, K.J. Bitterman, and H.Y. Cohen et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
94. J.A. Baur, Z. Ungvari, R.K. Minor, D.G. Le Couteur, and R. de Cabo Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 11 2012 443 461
95. M. Kaeberlein, T. McDonagh, and B. Heltweg et al. Substrate specific activation of sirtuins by resveratrol J Biol Chem 280 2005 17038 17045
96. M.T. Borra, B.C. Smith, and J.M. Denu Mechanism of human SIRT1 activation by resveratrol J Biol Chem 280 2005 17187 17195
97. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
98. B.P. Hubbard, A.P. Gomes, and H. Dai et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators Science 339 2013 1216 1219
99. R.A. Miller, D.E. Harrison, and C.M. Astle et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice J Gerontol A Biol Sci Med Sci 66 2011 191 201
100. K.L. Hector, M. Lagisz, and S. Nakagawa The effect of resveratrol on longevity across species: a meta-Analysis Biol Lett 8 2012 790 793
101. R. Strong, R.A. Miller, and C.M. Astle et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice J Gerontol A Biol Sci Med Sci 68 2013 6 16
102. X. Yu, and G. Li Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri Exp Gerontol 47 2012 940 949
103. T. Genade, and D.M. Lang Resveratrol extends lifespan and preserves glia but not neurons of the Nothobranchius guentheri optic tectum Exp Gerontol 48 2013 202 212
104. A. Martin-Montalvo, E.M. Mercken, and S.J. Mitchell et al. Metformin improves healthspan and lifespan in mice Nat Commun 4 2013 2192
105. V.N. Anisimov Metformin for aging and cancer prevention Aging (Albany NY) 2 2010 760 774
106. M.N. Pollak Investigating metformin for cancer prevention and treatment: the end of the beginning Cancer Discov 2 2012 778 790
107. F. Ovalle Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes Clin Ther 33 2011 393 407
108. D.G. Hardie, F.A. Ross, and S.A. Hawley AMP-Activated protein kinase: a target for drugs both ancient and modern Chem Biol 19 2012 1222 1236
109. G.G. Schiattarella, C. Perrino, and F. Magliulo et al. Statins and the elderly: recent evidence and current indications Aging Clin Exp Res 24 3 Suppl 2012 47 55
110. G. Kolovou, V. Kolovou, I. Vasiliadis, A.S. Wierzbicki, and D.P. Mikhailidis Ideal lipid profile and genes for an extended life span Curr Opin Cardiol 26 2011 348 355
111. F. Olivieri, I. Mazzanti, and A.M. Abbatecola et al. Telomere/telomerase system: a new target of statins pleiotropic effect? Curr Vasc Pharmacol 10 2012 216 224
112. F.J. Ramos, S.C. Chen, and M.G. Garelick et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival Sci Transl Med 4 2012 144ra03
113. K.H. Schreiber, and B.K. Kennedy When lamins go bad: nuclear structure and disease Cell 152 2013 1365 1375
114. V. Butin-Israeli, S.A. Adam, A.E. Goldman, and R.D. Goldman Nuclear lamin functions and disease Trends Genet 28 2012 464 471
115. T. Sullivan, D. Escalante-Alcalde, and H. Bhatt et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy J Cell Biol 147 1999 913 920
116. V. Nikolova, C. Leimena, and A.C. McMahon et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice J Clin Invest 113 2004 357 369
117. J.C. Choi, A. Muchir, and W. Wu et al. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation Sci Transl Med 4 2012 144ra102
118. S. Sengupta, T.R. Peterson, M. Laplante, S. Oh, and D.M. Sabatini mTORC1 controls fasting-induced ketogenesis and its modulation by ageing Nature 468 2010 1100 1104
119. M. Lafontaine-Lacasse, D. Richard, and F. Picard Effects of age and gender on Sirt 1 mRNA expressions in the hypothalamus of the mouse Neurosci Lett 480 2010 1 3
120. K.M. Ramsey, K.F. Mills, A. Satoh, and S. Imai Age-Associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice Aging Cell 7 2008 78 88